← All stocks

Dermata Therapeutics, Inc.

DRMA Net buying
CIK 0001853816 #5398 in the set updated 21 Sep 2026
Bought (12 mo)
$1.27K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$13.09
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$13.09
1 of 1 sales
Net
+$1.26K
+$1.26K against sales at will

By person

6 insiders · 2 transactions
1.2×

Gerald T. Proehl holds only 1.2 times base salary in stock. $348.26K of shares against $280.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Gerald T. Proehl last reported holding, valued at $1.19, the price Common Stock was last bought or sold at on the open market here, on 16 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Bedoya-Toro Munera Maria E
SVP, Regulatory Affairs
$1.27K (1)
+$1.27K
1,012
$1.20K
+8,333%
Scott Kathleen D.
Director
$13.09 (1)
−$13.09
0
$0.00
−100.0%
PROEHL GERALD T
PRESIDENT, CHAIRMAN, CEO
292,631
$348.26K
Van Hoose Kyri K.
SVP, CFO
232,463
$276.65K
FISHER MARY
Director
196,946
$234.39K
+207,212%
HALE DAVID F
Director
80,957
$96.35K
+3,553%

No percentages here. This company's share count has moved by a factor of 8.0 over the window, from 681,557 to 5,430,648 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Scott Kathleen D.
16 Jun 2026
Director
Sell
11
$1.19
$13.09
Bedoya-Toro Munera Maria E
17 Feb 2026
SVP, Regulatory Affairs
Buy
1,000
$1.27
$1.27K

What was left out

Form 4 filings counted 17
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 1,007,402
History held since 17 Aug 2021